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We present an explicit solvent alchemical free-energy method for optimizing the           
partial charges of a ligand to maximize the binding affinity with a receptor. This              
methodology can be applied to known ligand-protein complexes to determine an           
optimized set of ligand partial atomic changes. Three protein-ligand complexes have           
been optimized in this work: FXa, P38 and the androgen receptor. The sets of              
optimized charges can be used to identify design principles for chemical changes to             
the ligands which improve the binding affinity for all three systems. In this work,              
beneficial chemical mutations are generated from these principles and the resulting           
molecules tested using free-energy perturbation calculations. We show that three          
quarters of our chemical changes are predicted to improve the binding affinity, with             
an average improvement for the beneficial mutations of approximately 1 kcal/mol. In            
the cases where experimental data is available, the agreement between prediction           
and experiment is also good. The results demonstrate that charge optimization in            
explicit solvent is a useful tool for predicting beneficial chemical changes such as             



















In recent years, alchemical methods have garnered increasing attention in drug           
design ​1–6​. In particular, free energy perturbation (FEP) is now commonly used by             
pharmaceutical companies due to improvements in efficiency ​7​, more accurate force           
fields ​8,9 and increases in computational power. Based on the Zwanzig equation ​10,11​,             
it is common to use FEP calculations in drug design to calculate the relative binding               
affinity of two molecules ​11–14​. This relative free energy, , can be defined using         GΔ AB      
the Zwanzig equation, as shown in Equation (1), as the free energy difference             
between thermodynamic states A and B.  
 
                                 (1)G  T ln<  Δ AB =  − k e−((E −E )/kT )B A >A   
 
With as Boltzmann's constant, temperature, and as the potential energies k   T  EA   EB      
of the system calculated using the Hamiltonian of state A and B and a state             < . >A   
average over system A. Typically in free energy calculations Equation (1) is            
expanded upon to include sampling from both states A and B ​15 or sampling from               
intermediate states ​7​. This is done to improve the sampling overlap between end             
states. The drawback here is that for every relative binding affinity calculation,            
lengthy molecular dynamics (MD) simulations must be performed for all end and            
intermediate states. If, however, the perturbation between end states remains small           
enough, such that the overlap between end states is large, Equation (1) is sufficient              
without any intermediate states. Applying Equation (1) with no intermediate states is            
referred to as single step perturbation (SSP) and this is the primary free energy              
method used in this work. Numerous studies have used SSP ​16–19​, demonstrating            
that it is applicable to relative free energy calculations ​20,21 and can be significantly              
faster than standard FEP ​22​. Most recently, the authors of this paper have used SSP               
to perform computational fluorine scanning ​23​. We now apply SSP with the goal of              
optimizing ligand partial charges.  
 
Charge optimization was developed by Tidor and co-workers using an implicit water            
treatment of electrostatics ​24,25​. Poisson-Boltzmann calculations are performed on the          
bound and unbound states in order to find the optimal partial charges of a given               
molecule ​26–29​. This approach has since been used by other academic groups ​30,31​,             
employed in industry ​32​, and been extended to consider induced fit effects ​33​.             
However, the approach suffers from the deficiencies of all implicit water approaches:            
it is unable to deal effectively with interfacial water molecules. These occur            
commonly and are very difficult to treat effectively with implicit solvent approaches.            
The accuracy of implicit water models is lacking for many types of free energy              
calculations ​34–36​, particularly relevant here are implicit model’s shortcomings relative          
to explicit models for binding free energies ​37​. Additionally, whilst previous work has             
considered flexibility in the ligand, the receptor and complex were assumed to be             
rigid. It is known that this may play a significant role in binding free energies ​33​. Due                 
to advances in available computing power, explicit water approaches to charge           
optimization are now possible. We propose to exploit these computational advances           
by applying SSP to the bound and unbound states of small molecule inhibitors to              
develop a method for electrostatic charge optimization in explicit solvent. 
 
Combining SSP with explicit water MD calculations and flexible receptors and           
complexes has the potential to develop a more accurate charge optimizer. To carry             
out these charge optimizations, we developed a tool to automate their execution.            
This tool is freely available at ​https://github.com/adw62/Ligand_Charge_Optimiser​.       
Our ligand charge optimizer uses OpenMM ​38 as both an MD engine and a tool to                
create the modified alchemical systems. The software will generate all of the            
required mutant ligands from an input wild type ligand. These mutants are            





We optimize the ligand partial charges for three protein test cases: FXa, P38 kinase,              
and the androgen receptor. The chemical structures of the ligands studied are shown             
in Table (1). The ligands were built from highly related molecules in the Protein              
Databank ​39​: 2RA0 ​40 (FXa), 3S3I ​41 (P38), and 2NW4 ​42 (androgen receptor). These              
small modifications are made from the PDB to allow comparison with experimental            
data ​40–42​. Superpositions of the molecules in the original PDB and the modified             
molecules are shown in Figures (S2-S4). 
 
Table (1): Name of the target for each system with ligands 2D chemical structure              
and the PDBIDs of the target ligand complex. 
 
Target Ligand PDBIDs 
Factor Xa  2RA0​40 
P38  3S3I​41  





To prepare the Fxa, P38, and androgen receptor systems the non-standard residues            
were converted to their standard equivalents with pdbfixer ​43​. Selenomethionines          
were changed to methionines and missing sidechains were added using          
Schrödinger’s Preparation Wizard ​44​, ​which was also used to assign protonation state            
of all ionizable residues. All buffer solvents and ions were removed. The hydrogen             
atom positions were then built using tleap and force field parameters and partial             
charges were assigned from the AMBER ff14SB force field ​9​. Parameters for the             
inhibitors were generated using Antechamber ​45 with AMBER GAFF 2 ​46 and            
AM1-BCC ​47​. These structures and parameters were then passed to YANK’s ​48            
0.23.7 automatic setup pipeline to build solvated ligand-protein and ligand systems.           
For solvation, TIP4P-EW ​49 was used. A salt concentration of 150 mM and any              
required counter-ions were added using sodium and chloride ions. In every case, the             





MD sampling in this work is collected to compute SSP and FEP relative free              
energies, the amount of MD sampling varies for each application in this work and so               
is stated explicitly for each case in the relevant section. All simulations were             
performed with OpenMM 7.3.0 ​43 as follows. First, OpenMM’s default minimizer was            
used to minimize all structures. Then equilibration was performed in the NPT            
ensemble at 300 ​k and 1 ​atm using a Langevin integrator and Monte Carlo barostat               
for 250 ​ps​. MD simulations were performed in the NPT ensemble using a time step               
of 2 ​fs. Van der Waals interactions were truncated at 11.0 Å with switching at 9.0 ​Å​.                 
Electrostatics were modeled using particle mesh Ewald method with a cutoff of 11.0             
Å​. All other simulation parameters were left as default. Snapshots were collected            






The objective function of this optimization was .       G (q ) ΔGΔ binding i −  original G (q )Δ binding i  
was defined as the difference in free energy between the bound and unbound states              
of the ligand and target for a ligand with charges . was defined as the          qi  GΔ original     
difference in free energy between the bound and unbound states of the ligand and              
target for a ligand with the charges of the original unoptimized ligand. is            GΔ original  




Where are the charges of the ligand and the charges for iteration of the qi        qi, n     n   
optimization, m is the number of atoms in the ligand and the total net           et chargen     
charge of the ligand. Equation (2.1) constrains the net charge of the ligand to be               
constant. Equation (2.2) constrains the root mean squared difference between the           
ligands original charges, , and the charges to be less than some value  qi, 0    qi, n+1         
. These were chosen to limit the change in to a sensiblemsd limitr   msd limitsr        ΔGΔ total    
range < 10 kcal/mol. Without this limit, the optimization continued to very large             
unphysical values of because atomic partial charges can reach unphysical   ΔGΔ total         
values. The results of an unconstrained optimization can be seen in Figures (S17 -              
S19). Equation (2.3) constrains the perturbation to each atom to be less than 0.01             e  
per iteration, where is the elementary charge. With this limit of 0.01 a   e           e   
determination of how much sampling was required to give converged calculation of            
with a perturbation to each atom of 0.01 was made in Figure (S14). TheGΔ binding         e       
amount of sampling needed was determined to be 2.5 ​ns​, this was then the amount               
of sampling used in this work to calculate the objective and gradient for each              
optimization step. The algorithm which was used to find a local minimum in this              
objective function was the SciPy 1.1.0 ​50 implementation of the Sequential Least            
Squares Programming algorithm ​51​. 
 
The primary calculations in this work were calculated as follows, first we       ΔGΔ bindings       
applied SSP theory to calculate in the bound and unbound     GΔ unperturbed−>perturbed       
states as shown in Equation (3).  
 
                 (3)G  T ln<Δ unperturbed−>perturbed =  − k e−((E −E )/kT )perturbed unperturbed >unperturbed  
 
and are the potential energies of the system calculated using theEperturbed   Eunperturbed            
Hamiltonian of the perturbed system and the unperturbed systems respectively. To           
change Hamatonians, the charges were switched from unperturbed to pertubed          
values, however, Lennard-Jones, bonded, angle and torsion parameters did not          
change. was then constructed as shown in Equation (4). With ΔGΔ binding           
and as calculated inGΔ boundunperturbed−>perturbed   GΔ
unbound
unperturbed−>perturbed   GΔ unperturbed−>perturbed    
the bound and unbound states of the ligand and target.  
 






Note that is equal to the objective function in equation 2 if we take  ΔGΔ binding             
equations 3-4 and set the state as the ligand with the original     nperturbedu         
unoptimized charges and the  state as the ligand with charges .erturbedp qi  
 
To calculate the gradient of the objective function in each direction in charge space a               
finite difference was calculated as shown in Equation (5). 
 
                     (5)∇(ΔG (q ) ΔG )binding i −  original  =  h
ΔG (q +h) − ΔG (q )  binding i
 
binding i  
 
Where is a finite difference of 0.00015 . The numerator of the RHS of Equation h        e         
(5) is a and can be calculated using an SSP approach as detailed in   ΔGΔ binding            
Equation (3, 4) where are the charges and the    qi   nperturbedu   qi + h  erturbedp
charges. This calculation of the gradient shows the advantage of SSP, as numerous             
(10s-100s) of evaluations of are required, one for each direction in charge    ΔGΔ binding         
space. This is between molecules that are extremely similar, differing only  ΔGΔ binding          
by 0.00015 in one atom’s partial charge. There is therefore likely to be a large  e               
sampling overlap between these states allowing SSP to be applied. Of note is that              
for each finite difference calculation the charge of the simulation box has been             
changed by 0.00015 . The potential for finite size effects ​52 caused by this change   e             
were investigated and the padding of the simulation with solvent chosen to negate             
these effects, see Figure (S15). 
 
To delineate between the free energy change for individual optimization steps and            
the free energy change between the original and final optimized ligands, these will             
be defined as and respectively. Since an SSP method is being   ΔGΔ step   ΔGΔ total          
used, efforts were made to avoid poor overlap between the end states of any              
perturbations. To achieve this, the system was resampled after every optimization           
step. With the new sampling, the perturbed system could be redefined as a new              
unperturbed system after each optimization step. If this was not done then the             
difference between the perturbed and unperturbed systems would grow over the           
course of the optimization, reducing the overlap in sampling and so reducing the             
applicability of SSP. Resampling had an additional advantage as it allowed for a             
calculation of a reverse alchemical step. Therefore, for both the forwards       ΔGΔ step      
and backwards alchemical transformation were calculated for every step and the           





The optimization in this work gave a set of optimized charges and an associated              
for going from the original set of ligand charges to the optimal set, namedΔGΔ binding               
above as . To validate the given by the optimization, we compared  ΔGΔ total     ΔGΔ total        
it against standard alchemical relative binding free energy calculations using the           
MBAR ​7 estimator applied to the system with the original and optimized set of              
charges as end states. These calculations were run using the Ligand Charge            
Optimiser package as follows. For these calculations 12 equally spaced lambda           
windows (except when explicitly stated otherwise) were used. Between these          
windows the charge parameters were interpolated simultaneously from the original to           
optimized charges. All windows were sampled independently with 2 ​ns of Langevin            
dynamics totaling 24 ​ns ​of sampling. All simulation conditions were identical to the             
optimization MD calculations described above. The samples collected in each          
intermediate state were decorrelated based on an estimate of the statistical           
inefficiency of the reduced potentials time series before carrying out the MBAR            
analysis with the PyMBAR 3.0.1 ​7​.  
 
In addition to testing the we also wished to calculate the for a set     ΔGΔ total        ΔGΔ binding    
of chemical changes informed by the optimal charges. This is defined as         ΔGΔ binding    
and is the change in binding free energy between the original ligand andΔGΔ designed               
a designed ligand with some chemical mutation. To perform these calculations, the            
protocol was the same for the full FEP calculation of but with the following          ΔGΔ total      
additional considerations. Now, in addition to the charges, the van der Waals and             
bonded terms were all interpolated simultaneously from the original to the designed            
state. In the case of hydrogen to fluorine mutations the original hydrogen was             
constrained, therefore its associated C-H bond could not be interpolated to a C-F             
bond. When neglecting the interpolation of this bond the fluorine appeared at the             
position of the hydrogen, instead of the true physical position of the fluorine. To avoid               
this issue for fluorinations we used a hybrid topology approach where a massless             
interaction sites at the position of the mutation was added. This virtual site             
represents the fluorine and its position was defined relative to the position of the              
parent hydrogen such that the C-F distance is always 1.24 times the C-H distance ​53​.               
When mutating a hydrogen to fluorine, the relevant hydrogen was turned off and             
fluorine Lennard-Jones and charge parameters were applied to the additional site.           
When simulating these systems, all bonds to hydrogen were constrained. Since the            
position of the fluorine was defined relative to the position of its parent hydrogen it               
was also implicitly constrained. We therefore made the assumption that the C-F            
bond length oscillations were negligible. To prevent the hybrid topologies from           





Using the optimization methodology above, the partial atomistic charges of three           
ligand-target systems are optimized. For each optimization, we would like to inspect            
the convergence over the number of steps. A good metric to analyse the results of               
the optimization is the set of optimized charges taken as a vector. In the              
methodology, mention was made to limiting the RMSD between the original and            
optimized charges to some value . The values which are chosen for     msd limitr        
are 0.01, 0.03, and 0.05 . ​The optimization is therefore repeated with themsd limitr      e         
RMSD bound to these three values. With an RMSD bound of 0.01 , the optimizer is            e     
limited to seven steps as adequate convergence is seen at this point. For a larger               
RMSD, the convergence is slower and therefore for optimizations with RMSD           
bounds of 0.03 and 0.05 the optimizer is limited to 20 steps. To assess     e           
convergence across simulation steps, we take the dot product of the normalized            
vector of new charges with the normalized vector of original charges for each step of               
the optimization (see Figure (1)). 
 
 
Figure (1) : ​Dot product of the normalized optimized charges with the normalized             
original charges showing variation of charge vector direction with step. Results are            
shown for RMSD limits 0.01, 0.03 and 0.05 . With the FXa, P38 and androgen        e        
receptor systems labeled a), b) and c) respectively. 
  
Figure (1) show that the direction of the charge vectors over all systems and RMSDs               
are well converged. The direction of these charge vectors represents where the            
charge is being applied on the molecule and this is the information that will be used                
in the following section to make chemical mutations to improve . It can          ΔGΔ binding    
also be seen that the dot product between the original and optimized charges is              
different for different RMSDs. To quantify this difference, the dot product between            
the set of optimal charges obtained for RMSD 0.01 with 0.03 and 0.05 can be             e    
taken and the results of these projections can be seen in Table (2). Here we see that                 
sets of charges for the same system are pointing in the same direction. Thus only               
the value of the charge changes are dependant on the RMSD, whilst the direction              
and relative magnitude of the charge changes are completely consistent. This is an             
important result because it shows that the design principles identified by the            
approach will not depend on the arbitrary choice of the RMSD. The invariance in              
where the charge is being applied can also be seen by eye if the atoms are colored                 
by change in charge. Figures illustrating this are presented in the Figures (S5-S13)             
for all sets of optimized charge.  
 
Table (2) : ​Dot products of the normalized vector of optimal charges using an RMSD               
of 0.01  with the normalized vector of optimal charges using different RMSDs.qe   
 
RMSD ( )e  FXa P38 Androgen receptor 
0.01 1.00 1.00 1.00 
0.03 1.00 1.00 1.00 
0.05 0.99 0.98 0.99 
 
In Table (2) we can see the dot product of the optimized charges from the               
optimization with an RMSD of 0.01 with themselves returns 1.00 as expected. The      e         
dot product of the vector of charges with RMSD = 0.01 ​with RMSD = 0.03 ​also          e      e   
returns 1.00 as these vectors are extremely similar in direction. The dot product of              
the vector of charges with RMSD = 0.01 ​with RMSD = 0.05 ​returns        e      e   
approximately 1.00 as these vectors are extremely similar in direction but not as             
close as 0.01 ​with 0.03 ​. To summarize, each optimization for a system added   e    e           
the charge in approximately the same place. It is only the magnitude of this charge               
that varies with RMSD. We can also look at the convergence of ​with            ΔGΔ step   
optimisation step and this can be seen in Figure (2).  
 
 
Figure (2): ​Cumulative sum of averaged over three replicates for each step     ΔGΔ step         
of the optimizer. Three optimizations are shown with RMSD bound to 0.01, 0.03 and              
0.05 . With the FXa, P38 and androgen receptor systems labeled a), b) and c) e               
respectively. 
 
With an RMSD of 0.01 Figure (2) demonstrates that is well converged for     e      ΔGΔ step      
all systems. For a RMSDs of 0.03 or 0.05 the results are only well-converged for         e        
the androgen receptor system, Figure (2c). ​This suggests that for the         ΔGΔ step    
optimized set of charges is dependant on the RMSD and is slow to          ΔGΔ step     
converge for larger ligands such as those in the p38 and FXa test cases.              ΔGΔ total  
can be calculated between the original and the optimized charges with the            
cumulative sum of the SSP for all optimization step. This gives a     ΔGΔ step         ΔGΔ total
that will be termed as the . We compare this SSP for each set of      ΔΔGSSPtotal      ΔGΔ total      
optimized charges with full FEP calculations, see Table (3). These FEP calculations            
use the original and optimized charges as the two end states and the resulting              
 will be termed as the .ΔGΔ total ΔΔGtotal
FEP  
 
Table (3): ​Calculated for the set of optimal charges. SSP values   ΔGΔ total         ΔGΔ total   
are calculated by summing the average of forward and backwards SSP calculations            
made for each step of the optimizer. FEP values are calculated from an        ΔGΔ total       
alchemical transformation from the original charges to the optimal charges. SSP and            
FEP predictions are reported as the mean of three replicates with 95% confidence             
interval reported between square brackets computed as mean ​± t2⋅SEM, where t2 is             
the t-distribution statistic with two degrees of freedom, and SEM is the standard error              
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Table (3) shows that the SSP and FEP calculations are well agreed with an RMSD of                
0.01 (differing by less than 1.0 kcal/mol in all cases). For an RMSD of 0.03 and e                
0.05 , SSP and FEP are less well agreed (differing by more than 1.0 kcal/mol in e                
some cases). Table (3) also shows clearly that changing the RMSD changes the             
calculated . The relation here is that increasing the RMSD bound increases ΔGΔ total            
how much the charges can be changed and so increases the change in .             ΔGΔ total  
However, as discussed above, the convergence of is an unnecessary       ΔGΔ total     
condition, providing no additional information. It is only critical that the direction of the              
charge vectors are well converged and consistent for all RMSD values for all test              
cases, which as been shown in Figure (1) and Table (2), as it is this information that                 
will inform what chemical mutations are proposed for the ligands. As such we then              
use where the optimiser has placed the charge as a design tool to generate ideas for                
beneficial chemical mutations and this is presented in Figure (3). 
 
 
Figure (3): Panels a), b) and c) show the FXa, P38 and androgen receptor ligands               
with atoms coloured by change in charge relative to the original partial charges. The              
optimised charge is taken from the optimisation with RMSD bound to 0.03 . Blue            e   
represents atoms which are more negative and red represents atoms which are            
more positive. Selected sites for chemical modification are numbered.  
We developed specific design ideas to improve based on the changes in       ΔGΔ binding       
charge. First analyzing the Fxa ligand, three options are selected:  
 
● Replacing the hydrogen with a fluorine at position 1a. 
● Replacing the nitrogen with a carbon at position 2a.  
● Replacing one or more of the hydrogens with a fluorine atom on the methyl              
group at position 3a. 
 
Analyzing the P38 ligand, four options are selected:  
 
● Replacing the hydrogen with a fluorine at position 1b or 4b.  
● Replacing the nitrogen with a carbon at position 1b or 4b. 
● Replacing the oxygen with a sulphur at position 2b .  
● Replacing one or more of the hydrogens with a fluorine atom on the methyl              
group at position 3b.  
 
The final set of changes apply to the ligand of the androgen receptor with three               
options selected: 
 
● Replacing the oxygen with a sulphur at position 1c and 2c  
● Replacing the hydrogen with a fluorine at position 3c, 4c or 5c.  
● Replacing the bonded carbon with a nitrogen at positions 4c or 5c. 
 
for all of these changes was calculated using the FEP protocol discussedΔGΔ designed              
in the methods section. Each FEP calculation was performed in triplicate and the             
averaged results of these calculations can be seen in Table (4). 
 
Table (4): for proposed chemical mutations to the FXa, P38 and  ΔGΔ designed          
androgen receptor ligands calculated with FEP. The positions denoted numerically          
corresponds to numerical positions in Figure (3). 2D structures of the mutation are             
presented in the column labeled mutant. FEP predictions are reported as the mean             
value of three replicates with 95% confidence interval reported between square           
brackets computed as mean ​± t2⋅SEM, where t2 is the t-distribution statistic with two              
degrees of freedom, and SEM is the standard error of the mean computed from the               
sample standard deviation of the three independent replicate predictions. The          
asterisk label * indicates single or double fluorinations of a methyl. These are             
averaged over every hydrogen or pair of hydrogen in the methyl and as such this               
data represents the averaging of nine replicates with the confidence interval reported            
such that ​t2 is now the t-distribution statistic with eight degrees of freedom. ​The              
obelisk label ​† denotes calculations that were slow to converge and run with 24              
lambda windows of 2ns. The diesis ​‡ label denotes data taken from previous work of               
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The atoms indicated by the optimization to beneficially be more negative in Figure             
(3) line up with experimental work on these test cases ​40–42​. Mutants 1, 6, and 19 are                 
predicted by FEP to be beneficial (-2.2 kcal/mol, -2.2 kcal/mol, and -2.5 kcal/mol             
respectively) and this is in good agreement with experimental data (-2.1 kcal/mol,            
-2.3 kcal/mol, and -1.1 kcal/mol respectively). Experimental data does not exist for            
the remaining proposed mutations. However, 73% of the mutations in Table (6) are             
predicted to be favourable by FEP. Both the FXa and androgen systems have a              
higher success rate with 80% and 89% of ideas from charge optimization being             
beneficial as assessed by FEP respectively. P38 has a lower (though still promising)             




We have demonstrated ligand charge optimization in explicit solvent to be a useful             
tool to rationally design ligands with improved binding affinities. The electrostatics of            
three ligand receptor systems were systematically optimized using the alchemical          
SSP method, yielding sets of optimal ligand charges. These sets of optimal charges             
were used to generate design principles for chemical mutations to the ligands that             
would yield improved receptor binding affinity. These chemical mutations were          
assessed with a more rigorous FEP method. Using FEP, 73% of the predicted             
chemical mutations were found to be beneficial. The average improvement of the            
beneficial mutations was approximately 1 kcal/mol. In three of these cases,           
experimental data exists and is in excellent agreement with calculations, with           
mutants 1, 6, and 19 in Table (4) predicted by FEP to be beneficial (-2.2 kcal/mol,                
-2.2 kcal/mol, and -2.5 kcal/mol respectively) compared to the experimental data           
(-2.1 kcal/mol, -2.3 kcal/mol, and -1.1 kcal/mol respectively). 
 
The major advantage of SSP shown in this work is the calculation of the gradient.               
SSP allows for many highly related mutations to be assessed quickly, as is required              
to calculate the gradient via a finite difference method. For comparison, to collect 2.5              
ns of sampling for the FXa system with 99, 000 and 13, 000 atoms in the complex                 
and solvent systems respectively takes 29 minutes. To calculate a gradient from this             
sampling takes 15 minutes and so, including sampling, this totals to 44 minutes per              
gradient. To calculate a perturbation 0.00015 of with full FEP (assuming 1.0 ​ns of      e          
sampling converges , see Figure (S16) for convergence plot) takes 14  ΔGΔ binding          
minutes. With 58 charges in the FXa ligand, which must all be perturbed in the               
complex and solvent systems, this gives approximately 27 hours to calculate one            
gradient. This advantage would only be compounded if a more complex optimization            
scheme, which required a calculation of the Hessian, was used. Both these            
calculations of the gradient are run in parallel (see Supporting Information for            
parallelization strategy) across 4 NVIDIA P100 GPUs using OpenMM 7.3.0 and           
CUDA 10.0. 
 
This ligand charge optimization methodology could be easily extended by          
considering the optimization of any other parameter of the force field with respect to              
the binding free energy. For example, the van der Waals parameters could be             
‘optimized’. Additionally, the calculation for the gradient of force field parameters with            
respect to potential energies could be used in the systematic optimization of a small              
molecule force field. Since here we have demonstrated a methodology for quickly            
calculating gradients of force field parameters with respect to free energy this could             
lead to some interesting studies of force field optimization using experimental           
ligand-receptor binding energies as a target data set. This method is relatively            
unique in providing drug design principles from alchemical free-energy calculations          
along with a rationale for increases or decreases in binding due to specific changes              
to the ligand ​54​. 
 
In summary, we have presented a novel technique for identifying partial charges that             
optimize protein-ligand binding affinities and highlighted ways in which these          
predictions can be turned into design principles for drug discovery. The method is             
fast compared to traditional FEP, easy to interpret, and simple to test by using more               
thorough approaches such as MBAR. 
 
  
Supporting Information  
 
Figure (S1) 3D structures of ligands with all atoms named. Figures (S2-S4) showing             
superposition of ligands in PDBs and manually built ligands used in this work. Table              
(S1) contains original charges of ligands used in this work. Table (S2) contains             
optimised charges for all optimizations. Figures (S5-S13) show ligands colored by all            
set of optimised charges. Figure (S14) convergence plot for with sampling time         ΔGΔ     
calculated using SSP. Figure (S15) convergence plot for with box size        GΔ     
calculated using SSP. Figure (S16) convergence plot for with sampling time        ΔGΔ     
calculated using full FEP. Figure (S17) shows FXa ligand colored by a set of              
optimised charges from an optimization with no rmsd constraint. Figure (S18)           ΔGΔ  
plotted against step from an optimization for FXa with no rmsd constraint. Figure             
(S19) Dot product of the normalized optimized charges with the normalized original            
charges showing variation of charge vector direction with step for FXa with no rmsd              
constraint. Discussion of parallelization strategy for all calculations. 
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